XML 36 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2013
Dec. 31, 2012
Current assets:    
Cash and cash equivalents $ 118,303 $ 221,804
Short-term investments 166,998 89,475
Accounts receivable 16,812 9,843
Deferred Tax Assets, Net 19,974 1,014
Prepaid expenses and other current assets 7,414 2,427
Total current assets 329,501 324,563
Property and equipment, net of accumulated depreciation and amortization 778 339
Patents, net of accumulated amortization 296,272 313,529
Goodwill 30,149 30,149
Other assets 1,016 137
Total assets 657,716 668,717
Current liabilities:    
Accounts payable and accrued expenses / costs 16,310 9,485
Accrued patent acquisition related payments, current 8,750 0
Royalties and contingent legal fees payable 8,313 12,508
Total current liabilities 33,373 21,993
Deferred income taxes 17,748 27,831
Other liabilities 1,322 415
Total liabilities 52,443 50,239
Commitments and contingencies (Note 5)      
Stockholders' equity:    
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding 0 0
Common stock, par value $0.001 per share; 100,000,000 shares authorized; 49,922,626 and 49,160,844 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively 50 49
Treasury stock, at cost, 1,129,408 shares as of September 30, 2013 and December 31, 2012 (26,731) (26,731)
Additional paid-in capital 653,326 644,982
Accumulated comprehensive loss (783) (1,166)
Accumulated deficit (28,733) (5,632)
Total Acacia Research Corporation stockholders' equity 597,129 611,502
Noncontrolling interests in operating subsidiaries 8,144 6,976
Total stockholders' equity 605,273 618,478
Total liabilities and stockholders' equity $ 657,716 $ 668,717